1. Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model

   • Jennifer Walter-Yohrling
   • Bruce M. Pratt
   • Beverly A. Teicher

   Original Article 17 July 2003 Pages: 263 - 269

   

2. Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation

   • Karine Peron
   • Tara N. Jones
   • J. Thomas Pento

   Original Article 25 June 2003 Pages: 270 - 276

   

3. A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies

   • Chris Twelves
   • Martin Reck
   • Stan Kaye

   Original Article 25 June 2003 Pages: 277 - 281

4. Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

   • Marc Ychou
   • Jacqueline Duffour
   • Frédéric Pinguet

   Original Article 19 June 2003 Pages: 282 - 290

   

5. Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells

   • Sonali M. Smith
   • Susan M. Ludeman
   • M. Eileen Dolan

   Original Article 04 July 2003 Pages: 291 - 302

   

6. Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer

   • Robert I. Haddad
   • David A. Van Echo

   Original Article 25 June 2003 Pages: 303 - 306

7. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines

   • Ioannis A. Avramis
   • Walter E. Laug
   • Vassilios I. Avramis

   Original Article 25 June 2003 Pages: 307 - 318

   

8. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma

   • Masahide Nakajima
   • Kazutaka Hayashi
   • Takao Kondo

   Original Article 29 May 2003 Pages: 319 - 324

   

9. The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine

   • Leo J. Ostruszka
   • Donna S. Shewach

   Original Article 17 June 2003 Pages: 325 - 332

   

10. A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion

    • Jorge Leguizamo
    • Mary Quinn
    • Jean L. Grem

    Original Article 18 June 2003 Pages: 333 - 338

    

11. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

    • Juan José Reina
    • Jorge Aparicio
    • José Andrés Moreno-Nogueira

    Original Article 08 July 2003 Pages: 339 - 345

    

12. Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer

    • John F. R. Robertson
    • M. P. Harrison

    Short Communication 19 July 2003 Pages: 346 - 348